{"id":"https://openalex.org/W2018293318","doi":"https://doi.org/10.1002/hup.1015","title":"Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review","display_name":"Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-27","ids":{"openalex":"https://openalex.org/W2018293318","doi":"https://doi.org/10.1002/hup.1015","mag":"2018293318","pmid":"https://pubmed.ncbi.nlm.nih.gov/19330803"},"language":"en","primary_location":{"id":"doi:10.1002/hup.1015","doi":"https://doi.org/10.1002/hup.1015","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.1015","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018293318"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109801808","display_name":"Shigeru Morishita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shigeru Morishita","raw_affiliation_strings":["Depression Prevention Medical Center, Kyoto Jujo Rehabilitation Hospital, Minami-ku, Kyoto, Japan. s.morishita31@r9.dion.ne.jp","Department of Psychiatry, Kansai Medical University, Osaka, Japan","Depression Prevention Medical Center, Kyoto Jujo Rehabilitation Hospital, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Depression Prevention Medical Center, Kyoto Jujo Rehabilitation Hospital, Minami-ku, Kyoto, Japan. s.morishita31@r9.dion.ne.jp","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Kansai Medical University, Osaka, Japan","institution_ids":["https://openalex.org/I126884977"]},{"raw_affiliation_string":"Depression Prevention Medical Center, Kyoto Jujo Rehabilitation Hospital, Kyoto, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109801808"],"corresponding_institution_ids":["https://openalex.org/I126884977"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.8244,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.56427015,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"24","issue":"3","first_page":"191","last_page":"198"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9179999828338623},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9509999752044678},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.7080000042915344},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8759999871253967},{"id":"https://openalex.org/keywords/bipolar-depression","display_name":"bipolar depression","score":0.9940000176429749},{"id":"https://openalex.org/keywords/depression-recurrence-prevention","display_name":"depression recurrence prevention","score":0.8169999718666077},{"id":"https://openalex.org/keywords/gaba-system","display_name":"GABA system","score":0.8429999947547913},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.7239999771118164},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.8119999766349792},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.9890557527542114},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6276057958602905},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5972108244895935},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.5284466743469238},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5235028862953186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5111718773841858},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.4877346456050873},{"id":"https://openalex.org/C113280763","wikidata":"https://www.wikidata.org/wiki/Q2326546","display_name":"Subclinical infection","level":2,"score":0.4656800627708435},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.45970189571380615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39810681343078613},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.39184221625328064},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.36439114809036255},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3493651747703552},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2975479066371918},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21319061517715454},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.14029136300086975},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13669952750205994},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002998","descriptor_name":"Clonazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/hup.1015","doi":"https://doi.org/10.1002/hup.1015","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.1015","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},{"id":"pmid:19330803","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19330803","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W57016863","https://openalex.org/W59409234","https://openalex.org/W71355032","https://openalex.org/W93818550","https://openalex.org/W118879811","https://openalex.org/W158174910","https://openalex.org/W166564331","https://openalex.org/W1972677128","https://openalex.org/W1975683065","https://openalex.org/W1976593460","https://openalex.org/W1978859719","https://openalex.org/W1986916010","https://openalex.org/W1996894801","https://openalex.org/W1997704601","https://openalex.org/W2001071722","https://openalex.org/W2002883410","https://openalex.org/W2003250894","https://openalex.org/W2007290988","https://openalex.org/W2012797627","https://openalex.org/W2018282974","https://openalex.org/W2018445669","https://openalex.org/W2020761505","https://openalex.org/W2025935940","https://openalex.org/W2037931816","https://openalex.org/W2044204644","https://openalex.org/W2046970666","https://openalex.org/W2052992892","https://openalex.org/W2066777294","https://openalex.org/W2070311305","https://openalex.org/W2072704225","https://openalex.org/W2079079297","https://openalex.org/W2080932501","https://openalex.org/W2102460856","https://openalex.org/W2120003024","https://openalex.org/W2120692789","https://openalex.org/W2125293134","https://openalex.org/W2136440978","https://openalex.org/W2142644082","https://openalex.org/W2150026124","https://openalex.org/W2157227177","https://openalex.org/W2170435962","https://openalex.org/W2399674637","https://openalex.org/W2400301953","https://openalex.org/W2409117518","https://openalex.org/W2410386728","https://openalex.org/W2410851279","https://openalex.org/W2413705110","https://openalex.org/W2421287542","https://openalex.org/W2422801355","https://openalex.org/W4231608558","https://openalex.org/W4242505263"],"related_works":["https://openalex.org/W2142644082","https://openalex.org/W2052992892","https://openalex.org/W2025935940","https://openalex.org/W2018445669","https://openalex.org/W2367286738","https://openalex.org/W2170435962","https://openalex.org/W1973998428","https://openalex.org/W2070311305","https://openalex.org/W71355032","https://openalex.org/W2020761505"],"abstract_inverted_index":{"Clonazepam,":[0],"first":[1],"used":[2,9,65],"for":[3,29,37,50,89,92],"seizure":[4],"disorders,":[5],"is":[6,27,45,74,85],"now":[7],"increasingly":[8],"to":[10,20,41],"treat":[11],"affective":[12],"disorders.":[13],"We":[14],"summarize":[15],"the":[16,22,109,149],"use":[17,51],"of":[18,24,39,69,106,111,113,129],"clonazepam":[19,73,99,114],"improve":[21],"management":[23],"depression.":[25,94,107],"Clonazepam":[26,44],"useful":[28],"treatment-resistant":[30],"and/or":[31],"protracted":[32],"depression,":[33],"as":[34,36,59],"well":[35],"acceleration":[38],"response":[40,77],"conventional":[42],"antidepressants.":[43],"at":[46,66],"this":[47],"time":[48],"recommended":[49],"in":[52,138,143,154],"combination":[53],"with":[54,98],"SSRIs":[55],"(fluoxetine,":[56],"fluvoxamine,":[57],"sertraline)":[58],"an":[60],"antidepressant,":[61],"and":[62,152],"should":[63,78],"be":[64,79],"a":[67,76,101],"dosage":[68],"2.5-6.0":[70],"mg/day.":[71],"If":[72],"effective,":[75],"observed":[80],"within":[81],"2-4":[82],"weeks.":[83],"It":[84],"significantly":[86],"more":[87],"effective":[88],"unipolar":[90],"than":[91],"bipolar":[93],"Low-dose,":[95],"long-term":[96],"treatment":[97],"exhibits":[100],"prophylactic":[102],"effect":[103],"against":[104],"recurrence":[105],"Although":[108],"mechanism":[110],"action":[112],"has":[115],"not":[116],"yet":[117],"been":[118,123],"established,":[119],"some":[120],"investigators":[121],"have":[122],"suggested":[124],"that":[125],"it":[126],"involves":[127],"enhancement":[128],"anti-anxiety":[130],"effects,":[131],"anticonvulsant":[132],"effects":[133],"on":[134],"subclinical":[135],"epilepsy,":[136],"increase":[137],"5-HT/monoamine":[139],"synthesis":[140],"or":[141],"decrease":[142],"5-HT":[144],"receptor":[145],"sensitivity":[146],"mediated":[147],"through":[148],"GABA":[150,155],"system,":[151],"regulate":[153],"activity.":[156]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2018293318","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
